The Manila Times

ALX Oncology Advances Separate Clinical Trials Evaluating Investigational CD47-Inhibitor ...

First patient dosed in Phase 2 ASPEN-09-Breast trial evaluating evorpacept in combination with trastuzumab and physician’s ...